tiprankstipranks
NextCure Inc (NXTC)
NASDAQ:NXTC

NextCure (NXTC) Technical Analysis

281 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
NextCure Inc’s (NXTC) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting NextCure Inc is a Sell.
NextCure Inc’s (NXTC) 20-Day exponential moving average is 1.62, while NextCure Inc’s (NXTC) share price is $1.69, making it a Buy.
NextCure Inc’s (NXTC) 50-Day exponential moving average is 1.59, while NextCure Inc’s (NXTC) share price is $1.69, making it a Buy.

NextCure (NXTC) Pivot Points

Jul 23, 2024, 10:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.55
1.61
1.64
1.70
1.73
1.79
1.82
Fibonacci
1.61
1.64
1.66
1.70
1.73
1.75
1.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NextCure (NXTC) Moving Averages

Jul 23, 2024, 10:38 AM
Period
Simple
Exponential
MA5
1.72Sell
1.69Sell
MA10
1.65Buy
1.66Buy
MA20
1.62Buy
1.62Buy
MA50
1.57Buy
1.59Buy
MA100
1.64Buy
1.56Buy
MA200
1.44Buy
1.48Buy
NextCure Inc’s (NXTC) 10-Day exponential moving average is 1.66, while NextCure Inc’s (NXTC) share price is $1.69, making it a Buy.
NextCure Inc’s (NXTC) 100-Day exponential moving average is 1.56, while NextCure Inc’s (NXTC) share price is $1.69, making it a Buy.
NextCure Inc’s (NXTC) stock price is $1.69 and NextCure Inc’s (NXTC) 50-day simple moving average is 1.57, creating a Buy signal.
NextCure Inc’s (NXTC) stock price is $1.69 and NextCure Inc’s (NXTC) 100-day simple moving average is 1.64, creating a Buy signal.
NextCure Inc’s (NXTC) stock price is $1.69 and NextCure Inc’s (NXTC) 200-day simple moving average is 1.44, creating a Buy signal.

NextCure (NXTC) Technical Indicators

Jul 23, 2024, 10:38 AM
Name
Value
Implied Action
RSI (14)
55.67
Neutral
STOCH (9,6)
65.82
Neutral
STOCHRSI (14)
75.45
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
12.42
Buy
Williams %R
-29.05
Buy
CCI (14)
67.37
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
58.26
Neutral
ROC
6.29
Buy
NextCure Inc’s (NXTC) Relative Strength Index (RSI) is 55.67, creating a Neutral signal.
NextCure Inc’s (NXTC) Trend Strength Indicator (ADX) is 12.42, creating a Buy signal.
NextCure Inc’s (NXTC) Commodity Channel Index (CCI) is 67.37, creating a Neutral signal.
NextCure Inc’s (NXTC) Price Rate of Change (ROC) is 6.29, creating a Buy signal.

FAQ

Is NXTC a Buy, Hold, or Sell?
Based on NXTC’s technical indicators, NXTC is a Buy.
    What is NXTC’s RSI (14)?
    NXTC’s RSI (14) is 55.67, which suggests NXTC is a Neutral.
      What is NXTC’s MACD?
      NXTC’s MACD is 0.05, which suggests NXTC is a Sell.
        What is NXTC’s 5-day moving average?
        NXTC’s 5-day moving average is 1.72, which suggests NXTC is a Sell.
          What is NXTC’s 20-day moving average?
          NXTC 20-day moving average is 1.62, which suggests NXTC is a Buy.
            What is NXTC’s 50-day moving average?
            NXTC’s 50-day moving average is 1.57, which suggests NXTC is a Buy.
              What is NXTC’s 200-day moving average?
              NXTC’s 200-day moving average is 1.44, which suggests NXTC is a Buy.
                What is NXTC’s Williams % R (14)?
                NXTC’s Williams % R (14) is -29.05, which suggests NXTC is a Buy.
                  What is NXTC’s CCI (14)?
                  NXTC’s CCI (14) is 67.37, which suggests NXTC is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis